From: Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management
CYP1A2 inhibitors
Atazanavir
Cimetidine
Ciprofloxacin
Enoxacin
Ethinyl Estradiol
Fluvoxamine
Thiabendazole